Skip to main content

Stunting

0
Pipeline Programs
6
Companies
8
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
Dietary intakeN/A1 trial
EggN/A1 trial
Active Trials
NCT04025827Completed741Est. Feb 2021
NCT03902145Completed270Est. Aug 2017
One Biosciences
One BiosciencesFrance - Paris
2 programs
InterventionN/A1 trial
InterventionN/A1 trial
Active Trials
NCT03558464CompletedEst. Aug 2021
NCT03448484CompletedEst. Oct 2020
Purdue Pharma
Purdue PharmaCT - Stamford
1 program
Aflatoxin Birth Cohort Study Nepal (AflaCohort)N/A1 trial
Active Trials
NCT03312049Completed1,675Est. Mar 2019
Relief Therapeutics
Relief TherapeuticsSwitzerland - Geneva
1 program
Exposure to Growth MatsN/A1 trial
Active Trials
NCT04579328Unknown1,019Est. Jul 2021
Novita Pharmaceuticals
1 program
Food-based Approach Development to Fulfil Amino Acid Gap by Considering the Intestinal Permeability N/A1 trial
Active Trials
NCT04157413Unknown172Est. Apr 2020
Alliance Pharmaceuticals
1 program
SpirulinaN/A1 trial
Active Trials
NCT03523182Completed501Est. Jan 2018

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Relief TherapeuticsExposure to Growth Mats
Novita PharmaceuticalsFood-based Approach Development to Fulfil Amino Acid Gap by Considering the Intestinal Permeability
Human BioSciencesDietary intake
One BiosciencesIntervention
One BiosciencesIntervention
Human BioSciencesEgg
Purdue PharmaAflatoxin Birth Cohort Study Nepal (AflaCohort)
Alliance PharmaceuticalsSpirulina

Clinical Trials (8)

Total enrollment: 4,378 patients across 8 trials

NCT04579328Relief TherapeuticsExposure to Growth Mats

Impact of Life-size Growth Charts on Understanding of Stunting

Start: Oct 2020Est. completion: Jul 20211,019 patients
N/AUnknown
NCT04157413Novita PharmaceuticalsFood-based Approach Development to Fulfil Amino Acid Gap by Considering the Intestinal Permeability

Food-based Approach Development to Fulfil Amino Acid Gap by Considering the Intestinal Permeability of Children

Start: Jan 2020Est. completion: Apr 2020172 patients
N/AUnknown
NCT04025827Human BioSciencesDietary intake

Weight Patterns in the Month After Birth

Start: Apr 2019Est. completion: Feb 2021741 patients
N/ACompleted
NCT03558464One BiosciencesIntervention

Effectiveness Study During the First 1,000 Days in Kenya

Start: Jun 2018Est. completion: Aug 2021
N/ACompleted
NCT03448484One BiosciencesIntervention

Cluster Randomized, Parallel-group, Prospective, Follow-up Effectiveness Study in Kenyan Children 6-35 Months

Start: Mar 2018Est. completion: Oct 2020
N/ACompleted
NCT03902145Human BioSciencesEgg

LULUN PROJECT II - Cohort Follow-up Study

Start: Jun 2017Est. completion: Aug 2017270 patients
N/ACompleted
NCT03312049Purdue PharmaAflatoxin Birth Cohort Study Nepal (AflaCohort)

Aflatoxin Birth Cohort Study Nepal (AflaCohort)

Start: Jul 2015Est. completion: Mar 20191,675 patients
N/ACompleted
NCT03523182Alliance PharmaceuticalsSpirulina

Spirulina Supplementation and Infant Growth, Morbidity and Motor Development

Start: Mar 2015Est. completion: Jan 2018501 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.